The MRI-guided neurosurgical ablation market share emerges as a beacon of progress, poised for remarkable growth at a compound annual growth rate (CAGR) of 5% from 2022 to 2028. With its valuation projected to soar from US$ 154 million in 2021 to a staggering US$ 216.3 million, this groundbreaking technology ushers in a new era …